Assessing diabetes risk

Know more sooner—identify prediabetes and high-risk patients

We offer several diabetes lab tests that will help you make a difference earlier for more patients. With our diabetes risk panels, you’ll be able to identify more patients with prediabetes who are at high risk of developing diabetes. Recognizing risk earlier means you can do more to halt or delay disease progression—as soon as possible.

Make a difference with our diabetes laboratory test features

We strive to be the leader in diabetes laboratory testing, which is why our diabetes screening panels provide you with some key advantages:

  • Combined glucose and HbA1c—current ADA guidelines call for testing either glucose or HbA1c; however, recent studies have shown that testing for both provides greater accuracy in identifying prediabetes than does testing for either marker alone1-4
  • 8-Year Framingham Diabetes Risk Score—optional and available at no additional cost, this score was developed by the landmark Framingham Study Group and provides a percentage risk of developing diabetes over the next 8 years5

  • Graphical report format—supports your discussions with patients by helping you clearly communicate risk

Learn more about the tests we offer for assessing diabetes risk

We offer a variety of diabetes risk panels to meet the needs of your particular patients and your practice. Choose from the basic Diabetes Risk Panel with Score or opt for one that also offers insight into cardiovascular risk.

Learn about making a differential diagnosis of diabetes

Let us help you know what’s ahead

Contact a Quest Diagnostics Sales Representative to learn more
1.866.MYQUEST (1.866.697.8378)

Want to learn more about ADA guidelines-based testing?
Watch the webinar

View sample report

1 Schöttker B, et al. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes
   and implications for screening. Eur J Epidemiol. 2011;26:779-787.

2 Sato KK, et al. Combined measurement of fasting plasma glucose and A1c is effective for the prediction
   of type 2 diabetes. The Kansai Healthcare Study. Diabetes Care. 2009;32:644-646.

3 Soulimane S, et al. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and
   D.E.S.I.R. Diab Res Clin Pract. 2012;96:392-399.

4 Wang W, et al. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes.
   Diabetes Care. 2011;34:363-368.

5 Wilson PWF, et al. Prediction of incident diabetes mellitus in middle-aged adults. The Framingham
   Offspring Study. Arch Intern Med. 2007;167:1068-1074.